Impact of antiretroviral therapy on risky sexual behaviour in people living with HIV and AIDS (PLWHA) in Lusaka District of Zambia by Chilufya, Patrick Mukuka
Impact of antiretroviral therapy on risky sexual behaviour in people living with 
HIV and AIDS (PLWHA) in Lusaka District of Zambia 
 
 
by 
 
 
Patrick Mukuka Chilufya 
 
 
 
 
 
 
 
Assignment presented in fulfilment of the requirements for the degree of Master of 
Philosophy (HIV/AIDS Management) in the Faculty of Economic and Management 
Science at Stellenbosch University 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supervisor: Dr. Greg Munro  
December 2015 
  i 
DECLARATION 
By submitting this assignment electronically, I declare that the entirety of the work 
contained therein is my own, original work, that I am the sole author thereof (save to the 
extent explicitly otherwise stated), that reproduction and publication thereof by 
Stellenbosch University will not infringe any third party rights and that I have not previously 
in its entirety or in part submitted it for obtaining any qualification. 
December 2015 
Copyright © 2015 Stellenbosch University 
All rights reserved 
Stellenbosch University  https://scholar.sun.ac.za
 iii 
ABSTRACT 
 
The aim of the study was to investigate to what extent the availability of antiretroviral 
treatment has influenced sexual risk behavior practices in people living with HIV and AIDS 
(PLWHA) in order to provide suggestions to improve HIV prevention messages. 
 
The study was conducted among adult HIV patients on ART aged 18 and above and 
affiliated to the Network of Zambian People Living with HIV/AIDS (NZP+) in Lusaka 
District. A purposive sampling method was used to select study units and a sample of 40 
was selected. Data was collected from participants using a self-administered 
questionnaire. SPSS version 20 software computer package was used to analyze data. 
Chi- square was used to measure associations between dependent variables (risky 
sexual behavior and initiation of ART) and the independent variable (duration of time on 
ART). With the confidence interval set at 95%, the P value was used to ascertain the 
degree of significance by using the decision rule which rejects the null hypothesis if P 
value is equal or less than 0.05. 
 
The findings revealed that the participant's mean age was 2.8 ± 1.3 SD. More than half 
(68%, n=27) of the participants had adequate knowledge on HIV prevention while 90% 
(n=36) of participants had a good (positive) attitude towards ART. 82.5% (n=33) of the 
participants on ART had sexual intercourse in the last 6 month, and 21.2% (n=7) of these 
did not use a condom for secondary prevention. There was no significant correlation 
between being on ART and having sexual intercourse, condom usage or number of 
sexual partners OR (P value of 0.45 and 0.85), (P values 0.37 and 0.5) and (P value 0.34 
and 0.57) respectively. In multivariable analysis, the majority of the respondents (35.5%, 
n=11) indicated that continued sensitization would improve HIV prevention messages to 
support communities affected. Few (29%, n=9) stated that: "promoting abstinence among 
the youths or use of a condom for those that are sexually active and intensifying VCT 
campaign would reduce HIV transmission" and 7% (n=2) of the respondents suggested 
that; "involving the families and communities affected, civic, religious, and traditional 
leaders to educate both the young and adult citizens in schools, colleges and churches to 
support PLWH and fight against HIV-related stigma and discrimination. 
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A significant association was not found between an increase in risky sexual behavior or an 
upsurge in the occurrence of unprotected sex, initiation of ART and duration of being on 
ART. The majority (83%, n=15) of the respondents on ART for less than sixty months had 
protected sexual intercourse and 73% (n=11) on ART for sixty months and above also 
used protection.  This association was statistically not significant (Chi-square value 2.95. 
P value > 0.05). However; other studies need to explore these subjective interpretations 
further. 
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CHAPTER 1: BACKGROUND 
 
1.1. Interventions to prevent HIV/AIDS infection and transmission 
The HIV prevalence in Zambia is 13% according to the Demographic Health Survey of 
2013-14 (CSO,MOH & ICL, 2014).The National AIDS Strategic Framework for 2011 - 
2015 indicated that its main goal was to reduce the incidence rate in 2009 which was 
82,000 to 40,000 in 2015 (UNGASS, 2014).The interventions put in place to reduce the 
transmission of HIV included condom marketing and distribution, HIV counselling and 
Testing (HCT), Blood safety, prevention of sexually transmitted infections, Post Exposure 
Prophylaxis, Voluntary Medical Male Circumcision (VMMC), prevention of mother to Child 
Transmission (PMTCT) and Social and Behavior Change (SBC). Implementing partners 
with support from the National HIV/AIDS/STI/TB Council and Ministry of Health were 
carrying out these interventions countrywide. 
 
1.2. Antiretroviral therapy (ART) and high risk behaviour 
The Government of Zambia in the year 2002 embarked on the provision of antiretroviral 
therapy countrywide. In the initial phase U$ 3 million was allocated for the treatment of 
10,000 people living with HIV and AIDS. Later on in 2005, the government decided to 
make antiretroviral therapy free of charge at public health institutions. The introduction of 
antiretroviral treatment has brought hope in prolonging the lives of those living with HIV 
and AIDS. However, it was reported that the availability of antiretroviral drugs had resulted in 
some individuals resorting to high risk behaviors. With treatment available some 
individuals feel that it is acceptable to indulge in high risk behaviors after all if infected 
with HIV, they will receive medication and be able to lead a normal life. Thus the 
perception has been that some people are engaging in high risk behavior practices due to 
the availability of antiretroviral treatment. 
 
1.3. Research problem 
Only one known study similar in nature has been conducted in Zambia. In other countries 
similar researches were conducted on homogenous groups such persons living with HIV 
and AIDS as well as men who had sex with their fellow men (MSM). 
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The number of people living with HIV/AIDS in Zambia was estimated at 1,100,000 
(UNAIDS, 2013) and the disease has continued to rob Zambians of their social and 
economic security. Like many other countries in sub-Saharan Africa, high-risk sexual 
behavior, poverty, fear of stigma and discrimination and sexually transmitted diseases 
are major causes of the high HIV/AIDS prevalence in Zambia. Not much is known as to 
what extent the availability of antiretroviral treatment has influenced sexual behavior 
practices in people living with HIV and AIDS in Zambia particularly those who are on 
antiretroviral therapy. 
 
1.4. Research Question 
To what extent does the availability of antiretroviral therapy (ART) affect sexual risk 
behavior practices in people living with HIV and AIDS (PLWHA) in order to provide 
suggestions to improve HIV prevention message 
 
1.5. Aim 
To investigate to what extent the availability of antiretroviral treatment has influenced 
sexual risk behavior practices in people living with HIV and AIDS (PLWHA) in order to 
provide suggestions to improve HIV prevention messages. 
 
1.6. Objectives 
1. To determine knowledge about HIV prevention measures. 
2. To determine knowledge and attitude of antiretroviral treatment. 
3. To determine whether embarking on antiretroviral therapy has contributed towards 
sexually risky behavior. 
4. To provide guidelines on how to improve HIV prevention messages to support 
communities affected. 
 
1.7. Significance of the study 
The study will make a contribution to the field of HIV and AIDS by analyzing the current 
situation on treatment, prevention and risky sexual behavior and provide guidelines on 
how to improve on HIV prevention messages to all affected communities in Zambia. 
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The beneficiaries of this study will be HIV and AIDS program implementers, NGOs and 
National AIDS council. Current information will be obtained and this will be incorporated 
with their work to improve HIV and AIDS programing. 
 
Program implementers in the HIV and AIDS field will be able to evaluate their work against 
the study and thus fine-tune their work. The study will also help the Health Ministry in 
designing policies in the area of HIV and AIDS in Zambia. 
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CHAPTER 2: LITERATURE REVIEW 
 
2.1. Introduction 
HIV/AIDS has been reported as one of the most significant social problems affecting 
people from all walks of life as outlined in the introduction section. The review is aimed at 
establishing what is already known about the topic and to identify gaps in t he  existing 
literature. Several authors have written on many aspects of HIV/AIDS, its treatment with 
antiretroviral drugs and high risk sexual behaviors brought about due to the availability of 
these drugs. Some of these studies were done in Western countries and so the findings 
cannot be generalized to African countries since the prevalence of HIV infections is 
high in sub-Saharan Africa and Zambia (13%) in particular (CSO,MOH & ICL, 2014). 
 
2.2. Antiretroviral therapy and its benefits to patients 
According to UNAIDS in 2004 antiretroviral therapy was introduced in 1996 in developed 
countries and in 2004 in Sub-Saharan Africa. There has been an increase in the 
administration of highly active antiretroviral treatment in sub Saharan Africa over the past 
decade due to the concerted effort from the international community in the fight against 
the HIV scourge. 
 
According to the UNAIDS report on the access to antiretroviral therapy in Africa, it is 
stated in their status report on progress towards the 2015 targets that antiretroviral 
therapy does the following: 
 
 Life Saving -Approximately 5.5 million lives were saved between 1996 and 2012 in low 
and middle income countries. The majority of lives that were saved were from the sub-
Saharan African region. Antiretroviral therapy averts new HIV infections- Transmission 
risk of HIV is reduced by up to 96% as a result of antiretroviral therapy. 
 
One such similar study done by Cambiano et al (2011) reported that taking ART averts 
illness- HIV treatment increases immunity and thus in turn reducing the chances on one 
having opportunistic infections. This improves the quality of life of people infected and living 
with HIV. 
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It was further reported in this study that the risk of tuberculosis among people living with 
HIV is reduced by 65% as a result of antiretroviral therapy. 
 Saves finances and encourages development- Within a period of five years financial 
savings are generated as a result of HIV treatment. Expenditure on antiretroviral 
therapy also increases economic returns on initial investment. 
 Maintains production -People of productive age are able to return to work and 
continue being productive as a result of antiretroviral therapy which improves their health. 
 
2.3 Guidelines on the use of antiretroviral drugs 
The World Health Organization in 2013 published guidelines on the uses of antiretroviral 
drugs. These were as follows: 
 The initiation of antiretroviral therapy in all adult patients should be that of CD4 count 
of equal to or less than 500 cells per mm3. This includes symptomatic patients who 
are at WHO clinical stage 3 and 4 of the disease. Those patients who have a CD4 count of 
equal to 350 cells/mm3 or less should be treated as top priority. 
 Any HIV patient irrespective of his or her CD4 count who is diagnosed with active TB 
should be commenced on antiretroviral therapy. There is no need to wait until TB 
treatment is complete before commencement of ART. 
 Those HIV positive patients with active hepatitis B and with indication of severe liver 
disease should be commenced on ART irrespective of their CD4 count. This helps to 
prevent death in those HIV positive patients infected with hepatitis B. This is because 
scientific evidence has shown that some ARVs are active against the hepatitis B virus 
(e.g. a NRTI lamivudine). 
 Women who are HIV positive and are expecting or breastfeeding should be 
commenced on ART irrespective of their CD4 count or WHO clinical stage. This prevents 
mother to child transmission (MTCT) of HIV as well as through sexual contact 
 Those who are in sero-discordant relationships and are infected with HIV should be 
commenced on ART irrespective of the CD4 count. Evidence has shown that ART can 
prevent the transmission of HIV among sero-discordant couples 
 
As of December 2012 Africa was leading globally in the administration of antiretroviral 
therapy which included 7.6 million people on treatment in the sub-Saharan region. 
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Between 2006 and 2012 countries in southern and east Africa had doubled in scaling up 
the uptake of ART in people living with HIV and AIDS. There is also an increase in scaling 
up of uptake of ART in Central and Western Africa although the pace is slower. According to 
the WHO 2010 report on access to ART, It was reported that 80% or more of adults 
eligible for ART had been reached in at least 10 countries which include South Africa, 
Rwanda, Swaziland, Zambia, Eritrea, Kenya, Namibia, Zimbabwe, Botswana and Cape 
Verde. Noteworthy is the fact that more people were expected to have access to ART 
following the introduction of the 2013 WHO guidelines on access to ART. 
 
2.4 Antiretroviral therapy and risky sexual behaviors 
The success of ART has however gone along with many subjective interpretations of an 
upsurge in the occurrence of risky sexual behavior and unprotected sex. Whilst these 
interpretations are unconfirmed they can be said to be consistent research which have 
indicated that there might be an increase in the risky sexual behavior as a result of the 
availability of HAART in people living with HIV and AIDS (Bouhnik et al, 2002). Another 
similar study done by Kennedy et al, 2007 indicated that for example, as a result of the 
improvement of the quality of life of people living with HIV and AIDS due to the availability of 
HAART there is a likelihood of them being encouraged to recommence sexual activities 
which includes unprotected sex. 
 
The leading notion relating to insights of disease vulnerability and threat which argues 
that a change in the observed threat of HIV may result in the reduction in the concern 
about HIV, reduction of care in sexual practices and an increase in sexually transmitted 
infections and unprotected sex, was evidenced by the findings of three concurrent studies 
(Bouhnik et al, 2002; Stephenson et al, 2003; Stolte et al, 2006). 
 
A significant relationship between sexual behavior and HAART is not evident according to 
studies conducted in both industrialized and emerging countries (Crepaz, Hart & Marks, 
2004) (Kennedy, O’Reilly, Medley & Sweat, 2007). Of the three studies that have been 
conducted in developing countries, two of them have been in Uganda. It has become 
critical to review the hypothesized association between HAART and sexual behavior as 
treatment becomes more widely available. 
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A study was conducted in Uganda between 2003 and 2004 which was aimed at making 
an assessment in variation of risky sexual behaviors as well as transmission of HIV in 
those persons infected and on ART for a minimum of six months. The results indicated 
that out of the total 926 HIV infected adults who had since been enrolled in a home-based 
ART program, there was a significant reduction of sexual behavior by 70% (n=648) six 
months after commencing ART. Of the sexual acts that were risky 85% occurred in those 
couples that were married. 
 
Furthermore the study also reported a decline in the projected risk of HIV transmission by 
98%, from 45.7 to 0.9 per 1000 person years. It was thus concluded that the provision of 
ART together with voluntary counselling and testing alongside continued emphasis on 
HIV prevention modalities was related to the reduction of high risk sexual behavior and 
HIV transmission for those on treatment for the first six months. (Bunnell et al, 2006) 
 
A study amongst men who had sex with their fellow men was conducted with the objective of 
assessing the effect of highly active antiretroviral therapy (HAART) on their sexual 
behavior. This comprised of a HAART effect study which looked at unprotected sex 
practices which were anogenital as well as STI and sexual behavior trends. The study 
drew participants from the Amsterdam Cohort Studies (ACS) on men having sex with men 
which began in 1984. The subjects comprised of those both HIV negative and positive. 
 
Of the 365 subject who were HIV positive, were on HAART. The results of the study 
indicated that after the introduction of HAART unprotected sex was increasingly practiced 
as well as an increase in the cases of gonorrhea. There was also an increase in the 
number of unprotected sex with causal partners by those men who were HIV positive. It 
was concluded from this study that there was need to reinforce messages on safe sex on 
both HIV negative and positive individuals. 
 
A cross sectional study in the United States of America was conducted with the objective to 
investigate whether unprotected anal sex amongst men who have sex with men was 
associated to the attitudes towards antiretroviral treatment. The participants were 547 
men who have sex with men. Of these men 329 were HIV negative and 218 were positive. 
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The results obtained from this study indicate that more that 50 percent of the subjects 
who had anal sex and recently had unprotected receptive anal sex. Those respondents 
who agreed with the fact that HAART reduced transmission were more likely to have 
unreported unprotected receptive anal sex. 
 
A cross sectional study conducted in Mombasa, Kenya, which was aimed at revealing 
HIV disclosure to partners, condom usage and knowledge of partners HIV status, had 
interviewed 179 participants who were infected with HIV and on HAART for at least six 
months and 143 who were infected and were also receiving preventive therapy (PT) for at 
least a period of five months. 
 
The key findings of this study revealed the following: 
 45% (n=145) of all those who participated in the study were sexually active in the last 
six months. 
 Compared to those subjects on PT those who were on HAART indicated that they were 
unlikely to have sex with their single or multiple partners. 
 Those who were on HAART reported increased condom usage with their regular 
partners 
 Those that were on PT had a four times higher chance of having unprotected sex than 
ones who were receiving HAART. 
 
Thus it can be concluded rom the findings of the study that there was a lower chance of 
those on HAART indulging in risky behavior than those subjected to preventative therapy 
(PT). One can also conclude that there is no evidence that the commencement of HAART 
leads to increase of risky sexual behavior. (Sarna et al, 2005). 
 
A retrospective cohort study was conducted by Abby Makukula in 2008 at Mansa General 
Hospital in Mansa, Zambia as well as the University Teaching Hospital. The main 
objective of the study was to determine the impact of antiretroviral therapy on the risky 
sexual behavior practices of PLWHA on ART. The study population comprised of two 
groups. The first involved persons living with HIV and AIDS and on antiretroviral therapy. 
The second group comprised of people living with HIV and AIDS but not on antiretroviral 
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therapy. The sample size comprised of 119 PLWHA on ART and 111 not on ART. The 
results obtained on the comparison of risky sexual behavior outcomes were that there 
was a significant difference in the sexual activity pattern of the two groups. Those on ART 
were recorded to be more sexually active than those who were not on ART. Most subjects 
on ART experienced fewer admissions and were of better health. On risky behavior 
involving sexual intercourse with different types of partners the two study groups showed 
no statistical differences. The study failed to show whether there was higher risky sexual 
behavior when you compare the two groups under investigation. 
 
Recently in Togo at a regional hospital in Sokode between May and July 2013, an 
analytical cross-sectional survey was conducted to assess sexual risky behavior among 
people living with HIV and AIDS. These 291 research participants had been on 
antiretroviral therapy for a period of at least three months. The key findings of this 
research were that 74.6% were sexually active since initiation of antiretroviral treatment. 
Risky sexual relations amounted to 34.6%. The research thus concluded that unsafe sex 
amongst people living with HIV and AIDS who were receiving antiretroviral therapy was 
relatively high. The factors that contributed to high sexual risk behavior were named as 
non-adherence to ART; low levels of education; high consumption of alcohol prior to sex 
and during antiretroviral treatment. 
 
These high statistics were attributed to a reduction in the access to secondary prevention 
such as condoms and the desire for people living with HIV and AIDS to have children. 
(Yaya et al, 2014) 
 
Efforts have been made to explain the relationship between those who are on 
antiretroviral therapy and sexual behavior that is risky. The following factors have been 
explained as some of the reasons: 
 
I. Enhanced health and purposeful status combined with prolonged existence 
Antiretroviral treatment is said to enhance health and purposeful status of those persons 
living with HIV and AIDS. It may be said that the unintentional effect of antiretroviral 
treatment may be an upsurge in risky sexual behavior. Scheer et al in 2001 mentions that 
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this could be as a result of reduced fear about HIV transmission. Those persons who were 
on ART are said to have greater challenges in maintaining safer sex practices than those 
who are HIV positive and not on antiretroviral treatment. It is however stated that a person 
who displays symptoms of HIV infection as well as side effects from the drugs may 
experience loss of libido. 
 
II. Insights about antiretroviral therapy 
Rosenstock et al, 1994 in their Health Belief Model stress that the degree to which a 
disease is perceived to be severe has an influence on behavior change. The less a 
disease is perceived to be severe the less likely one is motivated to prevent transmission. 
Before the introduction of antiretroviral therapy there was great fear amongst people and 
much caution was taken in preventing the spread of the virus. HIV was seen as a condition 
that could not be treated and thus contracting the virus would mean an end to someone’s 
life. 
 
The introduction of antiretroviral therapy which has led to containing the virus and 
improving the quality of lives of individuals has changed the whole perception about HIV. 
With increasing knowledge that antiretroviral drug reduce the transmission of HIV much 
precaution towards safer tends to decrease. 
 
III. Facilities associated to ART 
Not much has been said about the influence that support services that have been provided to 
those people living with HIV has on risky sexual behaviors. Persons living with HIV may 
have access to services such as counselling, awareness programs and support groups. 
Through the counselling and support, correct and updated information is provided by 
experts and thus people are kept abreast on how to prevent HIV transmission. Thus the 
amount of support given to people living with HIV and AIDS is said to have an influence 
on the sexual behavior of those who have been affected. 
 
Therefore the study was undertaken in order to build upon the existing knowledge that 
has been gathered through previous research mentioned on the relationship between 
HAART and risky sexual behavior. From the reviewed literature on studies conducted in 
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both developed and developing countries one would observe that the sample consisted of 
mainly homogenous groups namely people living with HIV and AIDS as well as men who 
have sex with men. Not much research similar in nature was conducted in Zambia. 
Therefore there was need to carry out a similar study on the perception and sexual 
behaviors in the HAART availability context in Zambia as there is little existing knowledge 
about this. 
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CHAPTER 3: METHODOLOGY 
 
3.1. Introduction 
This chapter focuses on a number of aspects concerning the methodology, such as the 
research design, the nature of the sample, and the procedure. Furthermore, ethical 
matters, data management and analysis and finally methodological limitations. 
 
3.2. Study type and design 
The study under question was quantitative in nature. Quantitative methods are objective, 
formal and systematic and make use of numerical data to acquire information about 
phenomena (Cormack, 1991). The method can be easily replicated thus making it have a 
reliability that is high (Aiken, 2003). 
 
3.3. Study population and research setting 
The study was conducted amongst individual members affiliated to the Network of 
Zambian People Living with HIV/AIDS (NZP+) in Lusaka District. The network consists of 
about 50 community groups with each consisting 15 members. Thus the estimated total 
population was 750 members. Participants to this study that met the eligibility criteria were 
selected from the total population. 
 
3.4. Sample selection 
A non-probability purposive sampling method was used to come up with the sample in 
this study. This method allows the researcher to intentionally select subjects deemed to 
be pertinent to the subject under study (Patton, 1990).Thus the sample chosen was able to 
furnish the researcher with the required information. 
 
Fifty (50) individuals who met the criteria for this study were drawn from all Zambian 
People Living with HIV/AIDS in Lusaka District. From this target population, a sample of 
40 participants was then selected. 40 participants were considered to be representative 
and therefore reducing on sampling bias as the researcher was confident that results 
could reflect the characteristics of the target population. 
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3.5. Data collection tool 
A self-administered questionnaire in which the contents were arranged according to the 
major variables of interest as reflected in the specific objectives was used in this study to 
collect the information from the respondents. Questionnaires are less costly and able to 
generate results at a quick pace (Sarantakos, 1998). Apart from being convenient to the 
respondent they offer a great assurance of anonymity, wide coverage as well as 
enhanced objectivity. The questionnaire used in this study was semi- standardized 
containing both closed and open ended questions. This was done to enable expression of 
views when answering open ended questions as well as contrasts amongst 
respondents of closed ended questions. 
 
3.6. Data collection technique 
The following Procedure was used to collect data: 
 The purpose of the study was explained to the participants 
 Permission was sought from the participants so that they could answer the 
questionnaire 
 Confidentiality was maintained by ensuring that no names were written on the 
questionnaire instead numbers were used. Participants were asked to respond to the 
questions in the same order and the same set of options was provided for their response. 
The central topics that were explored included the following: Participants level of 
knowledge about HIV and AIDS prevention measures, knowledge and attitude towards 
antiretroviral therapy (ART), if embarking on ART has contributed to high risk sexual 
behaviours and guidelines to improve HIV prevention messages. Knowledge levels were 
measured using cut of points as shown in table 1 below. 
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Table: 1 Variables and cut off points 
 
Variables Cut off points Indicators 
Knowledge on HIV 
 
prevention  and ART 
Adequate knowledge Scores  8-12  correct on 
questions of knowledge 
Low Knowledge Scores 3-7  correct  
Not knowledgeable Scores 0-2 on questions 
assessing knowledge 
Attitude of patients on ART 
 
Towards risk sexual behaviors 
Positive Scores 3-5 correct on 
questions of attitude 
Negative Scores  0-2  on  questions of 
attitude  
 
 
3.7. Data analysis and presentation 
To analyze the data collected in this study, survey questionnaires were edited for 
completeness, uniformity, accuracy and consistency and then labelled. The responses 
from closed-ended questions were coded and then entered on the data spread sheet 
created in SPSS while responses from open-ended questions were processed by reading 
through the data in entirety to identify and group answers that belong together and then 
categorized according to major themes. The groups were then assigned numerical codes 
(1, 2, 3, 4…) and then entered on a data spread sheet and subjected to descriptive 
analysis using SPSS computer software version 20.This process allows for raw data to 
be summarized in form of percentages, frequencies, measures of central tendencies and 
measures of variability which include standard deviation, range and variance. Data from 
the findings was analyzed based on the target population of 50. Conclusion and 
generalizations were thus based on the target population and not the entire Network of 
Zambian People Living with HIV and AIDS in Lusaka District. 
 
The findings from this study were presented according to the sequence of questions and 
sections in the questionnaire (i.e. Section A, B, C, D and E) using frequency tables, pie 
charts and bar Graphs. 
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The use of graphs and pie charts in the presentation of findings made work presentable 
and easy to both read and understand. The frequency tables summarized the findings in 
meaningful ways thus giving understanding. Summaries of the points illustrated in the 
tables, pie charts and graphs were indicated. 
 
3.8. Inclusion Criteria 
The prospective research participants were; 
 Zambians Living with HIV and AIDS and receiving ART consistently based on the 
eligibility criteria which were issued by the World Health Organization (WHO) in June 
2013 outlined in literature review. 
 On treatment for at least a minimum of 12 months. 
 Not in any form of distress 
 Above the age of 18 years 
 Able to read and write in English 
 
3.9. Ethical considerations 
Clearance to carry out this research was obtained from relevant authorities: Stellenbosch 
University Research Ethics Committee and the Faculty of Economic and Management 
Science. An individual informed consent was obtained from the participant prior to 
commencement of the study. The individual participants were availed with the necessary 
information concerning the study and a decision was arrived at without having been 
subjected to intimidation, inducement or undue influence. Confidentiality and anonymity 
were maintained to the participants in that no names appeared on the questionnaires and 
their identity was not made public. 
 
They were assured that the information obtained from them was solely to be used for the 
purpose of the study and for statistical purposes. Furthermore the information obtained 
would also be of benefit to the individual, the organization as well as other stakeholders 
as it may provide solutions in mitigating the impact of HIV and AIDS. 
 
After completion, all questionnaires were put under lock and key in a cabinet to limit 
access to and ensure that the information obtained was only used by the researcher. 
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The discomfort and embarrassment arising as a result of questions asked about sexual 
behavior were addressed by emphasizing confidentiality and anonymity of the study. The 
questionnaire was also self-administered and did not involve face-to-face responses to 
the researcher. This also minimized on the risk of discomfort and embarrassment. 
 
To ensure that the research does not lead to openings of stigma, discrimination and 
judgment, language that does not communicate stigma was used. Participants were also 
respected and their autonomy, rights and dignity were protected. 
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CHAPTER 4: RESULTS AND DATA ANALYSIS 
 
Section A: 4.1. Socio-demographic characteristics of the respondents 
4.1.1 TABLE 2; Respondent’s demographic data 
  Frequency Percentages (%) 
Age (Years) 18-29 9 22.5% 
 30-39 6 15.0% 
 40-49 17 42.5% 
 50-59 1 2.5% 
 60 and above 7 17.5% 
 Total 40 100% 
    
Marital status Single 8 20.0% 
 Married 25 62.5% 
 divorced 0 0.0% 
 Widowed 7 17.5% 
 Total 40 100% 
    
Education level Primary 2 5.0% 
 Secondary 13 32.5% 
 Tertiary 20 50.0% 
 None 5 12.5% 
 Total 40 100% 
    
Gender Male 11 27.5% 
 Female 29 72.5% 
 Total 40 100% 
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The majority of the respondents (42.5%, n=17) were between the ages 40– 49 years while 
23% (n=9) were between the ages of 18-29 years. 62.5% (n=25) of the respondents were 
married, with only 50% (n=20) had tertiary education and 72.5% (n=29) were females. 
 
Section B: 4.2. Level of knowledge about HIV prevention measures 
 
4.2.1. Table 3. Respondent’s knowledge on HIV prevention 
Knowledge about HIV 
prevention N=40 
Frequency Percentage (%) 
Adequate knowledge 27 67.5% 
Low knowledge 13 32.5% 
Not knowledgeable 0 0.0% 
Total 40 100% 
 
 
The majority of the respondents (68%, n=27) had adequate knowledge on HIV prevention 
with 33% (n=13) having low knowledge 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
19  
P
e
rc
e
n
ta
g
e
 o
f 
k
n
o
w
le
d
g
e
 
4.2.2. Respondent’s Knowledge on HIV transmission prevention (N= 40) 
 
 
 
 
 
100 
 
90 
 
 
 
92.5% 
Knowledge on HIV transmission 
 
80                     
                                        65% 
70  
 
60 
 
50 
 
40 
 
 
 
    57.5% 
 
 
 
 
 
 
    42.5% 
 
30 
 
20 
 
10 
 
0 
Abstaining Using a condom 
correctly and 
consistently 
 
 
 
 
 
 
Avoiding infections 
and contaminated 
needles 
 
 
 
 
 
 
Remaining faithful to 
one uninfected 
partner 
 
          2.5% 
 
 
 
Don't know 
 
 
 
Knowledge 
 
 
 
 
 
 
 
 
 
 
Figure 1: Knowledge on HIV prevention 
 
The majority of respondents (92.5%, n=37) stated that HIV transmission could be 
prevented by using a condom when having sex, while 65% (n=26) said it could be 
prevented by abstaining. 57.5% (n=23) of the respondents indicated that it can be 
prevented by avoiding infections and contaminated needles with 42.5% (n=17) saying by 
remaining faithful to one uninfected partner. 
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Section C: 4.3. Knowledge and attitude towards antiretroviral therapy 
 
4.3.1. Table 4: Knowledge on antiretroviral therapy (N=40) 
  Responses Percent of Cases 
  N Percent 
Knowledge on 
antiretroviral 
therapy 
Cure HIV/AIDS 6 3.8% 15.0% 
Increase sickness  2 1.3% 5.0% 
Slow the progression of AIDS 23 14.6% 57.5% 
Decrease the amount of virus 
in the body 
24 15.2% 60.0% 
Improve immune system  26 16.5% 65.0% 
Reduce opportunistic 
infections 
24 15.2% 60.0% 
Prolongs life of people living 
with HIV and AIDS 
26 16.5% 65.0% 
Kill people 1 .6% 2.5% 
Increase the CD4 count  25 15.8% 62.5% 
Don't know 1 .6% 2.5% 
Total 158 100.0% 395.0% 
 
 
Table 3 shows that the majority (65%, n=26) of the respondents knew that ART improves 
immune system and prolongs life of people living with HIV and AIDS. 62.5% (n=25) of 
respondents said ART increase the CD4 count, 60.0% (n=24) indicated that ART 
decrease the amount of virus in the body and reduce opportunistic infections while 57.5% 
(n=23) said it slows the progression of AIDS. 
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4.3.2 Knowledge on when to start taking ARVs 
 
 
 
 
 
Knowledge on when to start ART 
 
0.9 
 
 
0.8 76.90% 
 
            0.7 
 
 
0.6 
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0.4 
 
 
 
0.3 
 
 
 
30.80% 
 
 
 
 
28.20% 
 
 
33.30% 
 
0.2 
 
 
0.1 
 
 
0 
 
 
 
Knowledge 
 
 
 
 
When they fall physically ill 
 
When CD4 count is 500 and below 
 
When they are unable to continue their daily activities due to 
illness 
 
 
 
Figure 2: The majority of the respondents (76.9%, n=31) were knowledgeable as they stated that 
ARVs should be started when CD4 count is ≤ 500 and 33.3% (n=13) indicated that not all positive 
people need to commence on ARVs. 
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4.3.1. Table 5: Attitude of the patients on ART towards risky sexual behavior 
 
Attitude about ART Correct response 
(Disagree to) 
Wrong response 
(Agree to) 
Totals 
A person on ART cannot 
transmit HIV 
(85% ,n=34) (15%, n=6) (100%, N=40) 
Patients on ART need not to 
use a condom 
(88%, n=35) (12%, n=5) (100%, N=40) 
See no need to use a condom 
with uninfected sexual partners 
(85%, n=34) (15%, n=6) (100%, N=40) 
Sex with a person on ART 
does not result in transmission 
of the virus 
(90%,n=36) (10%, n=4) (100%, N=40) 
 
Table 4 shows that the majority of the respondents had a good (positive) attitude with 
90% (n=36), stating that sex with a person on ART can still result in transmission of the 
HIV virus, 88% (n=35) indicating that patients on ART need to use a condom and 85% 
(n=34) stated that a condom should be used even with an uninfected partners. 
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Section D: 4.4. To determine whether embarking on antiretroviral therapy has 
contributed towards sexual risk behavior 
 
4.4.1. Participant on ART who had sexual intercourse in the last 6 months. (N=40) 
 
Have you had Sexual intercourse in the last 6 months 
 
17.5% NO 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
82.5% YES 
 
 
 
Figure 3: Of the 40 respondents who were on ART, the majority (82.5%, n=33) had sexual 
intercourse in the last 6 month. Only 17.5% (n=7) of the respondents did not have sexual 
intercourse. 
 
4.4.2. Table 6: Condom usage when having sex (N=33) 
  Frequency (n) Percent (%) Valid Percent 
Valid Yes 26 65.0% 78.8% 
No 7 17.5% 21.2% 
Total 33 82.5% 100.0% 
Missing 12 7 17.5%  
Total 40 100.0%  
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Table 5 Shows that of the 33 respondents who had sexual intercourse with partners in 
the last 6 months, the majority (78.8%, n=26) used a condom while 21.2% (n=7) did not 
use a condom. 
 
4.4.3. Reasons for using a condom with a sexual partner (N=26) 
 
 
 
 
 
 
 
 
 
 
 
 
 
73.10% 
 
 
 
 
 
19.20% 
 
 
7.70% 
 
A V O I D I N G T R A N S M I S S I O N 
O F  H I V  A N D  O T H E R  S T I S 
 
A V O I D  P R E G N A N C Y P R E S S U R E D  B Y  P A R T N E R  
 
RESPONSE 
 
 
Figure 4: Of the 26 respondents who used a condom, the majority (73.1%, n=19) stated 
that they used a condom in order to avoid transmission of the HIV virus and other STIs, 
19.20% (n=5) indicated that it was important to use a condom in order to avoid unplanned 
pregnancy and 7.7% (n=2) said they were pressured their partners to use a condom. 
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4.4.4 4.4.4: Reasons for not using a condom (N=7) 
 
 
 
 
Figure 5: Of the 7 respondents who did not use a condom, majority (88%, n=6) said were 
pressured by their partners not to use a condom while 12% (n=1) indicated that they were 
safe not to use a condom as they were on ART 
[CATEGORY 
NAME] 
[PERCENTAGE] 
pressured by 
partner 
[CATEGORY 
NAME] 
[PERCENTAGE] 
Safe because am 
on ART 
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4.4.5 Table 7. Association between the duration of time the participant had been on ART and 
having sexual intercourse 
 
 Have you ever had sexual 
intercourse in the last 6 
months 
Total P value 
 Yes No  
 
0.86 
Participants who have been on 
ARVs for less than 60 months 
18 (85.7%) 3 (14.3%) 21 (100.0%) 
Participants who have been on 
ARVs for 60 months and longer 
15 (78.9%) 4(21.1%) 19 (100.0%) 0.45 
 
 
There was no association between the duration of time the participant had been on ART and 
having sexual intercourse (p> 0.05). P value of 0.45 and 0.86 respectively (Not 
significant). The majority (85.7%, n=18) of the respondents on ART for less than 60 months 
had sexual intercourse during the last 6 months. 
 
4.4.6 Table 8. Association between duration of being on ART and condom usage 
when had sexual intercourse 
 Condom usage when had 
sexual intercourse 
Total P value 
 Yes No  
 
0.37 
Participants who have been on ARVs 
for less than 60 months 
15 (83%) 3 (17%) 18 (100.0%) 
Participants who have been on ARVs 
for 60 months and longer 
11 (73%) 4(27%) 15 (100.0%) 0.57 
 
Results indicate no association (p> 0.05) between the duration of time the participants had 
been on ART and whether they used a condom for secondary prevention. The majority 
(83%, n=15) of the respondents on ART for less than sixty months had protected sexual 
intercourse and 73% (n=11) on ART for sixty months and above also used a condom. P 
values 0.37 and 0.57 respectively (Not significant). 
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4.4.7. Table 9. Association between duration of being on ART and the number of 
partners the participant had sexual intercourse with 
 
 How many partners have you 
had sex with in the last 6 months 
Total P 
 
value 
 1 partner 2 partners  
 
0.34 
Participants who have been on 
ARVs for less than 60 months 
16 (88.9%) 2 (11.1%) 18 (100.0%) 
Participants who have been on 
ARVs for 60 months or longer 
12 (80%) 3(20%) 15 (100.0%) 0.57 
 
 
Table 14 shows no association between duration of being on ART and number of partners the 
respondent had sex with. The Majority (80%, n=12) of the respondents on ART for 60 months 
and above had one sexual partner. It was also found that 18 (88.9%) of the respondents 
who had been on ART for less than 60 months had one sexual partner. Chi- square value 
12.61. P value 0.34 and 0.57 respectively (Not significant). 
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Section E: 4.5. To provide guidelines on how to improve HIV prevention messages 
to support communities affected. 
 
4.6.1 Improvement of HIV prevention messages to support communities affected 
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Figure 6 shows that the majority of the respondents (35.5%, n=11) indicated that 
continued sensitization would improve HIV prevention messages to support communities 
affected. 
 
This was expressed in the statement “Lack of knowledge on HIV/AIDS-related issues in 
the community is one of the factors contributing to a rapid transmission of the disease 
especially among young and illiterate citizens.” 
 
Few participants (29%, n=9) stated that: “promoting abstinence among the youths or use 
of a condom for those that are sexually active and intensifying VCT campaign would 
reduce HIV transmission” 
 
Other participants (19.4%, n=6) indicated that both sensitization and prevention are vital 
and potential to fight the spread of HIV/AIDS. 
 
7% (n=2) of the respondents suggested that; “involving the families and communities 
affected, civic, religious, and traditional leaders to educate both the young and adult 
citizens in schools, colleges and churches to support and fight stigma and discrimination 
against people living with HIV would help.” 
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CHAPTER 5: DISCUSSION AND INTERPRETATION OF RESULTS 
 
5.1 Introduction 
This chapter interprets and discusses the findings of the study. The purpose of the 
discussion is to state and interpret the findings, give opinions and explain the implications of 
findings, and make suggestions for future research. Its main function is to answer the 
questions posed in the introduction, explain how the results support the answers and, 
how the answers fit in with existing knowledge on the topic. The findings were discussed 
according to the layout of the study objectives as follows; 
 
5.2 To determine knowledge about HIV prevention measures 
The findings showed that the majority of the respondents (68%, n=27) had heard about 
HIV/AIDS and had adequate knowledge on HIV prevention. This implies that the health 
workers are active in giving health education and sensitizing the community about 
HIV/AIDS. It can also be deduced that people living with HIV and AIDS interact with the 
health workers when seeking healthcare and it is likely that information is provided to 
them. It is noteworthy that these findings agree with the Zambia Demographic Health 
Survey 2013-14 which indicated that the knowledge about HIV and AIDS and its 
awareness among women and men remains very high at 99% and 100% respectively 
(CSO, MOH & ICL, 2014). 
 
The majority of respondents (92.5%, n=37) stated that HIV transmission can be prevented 
by correctly and consistently using a condom when having sex, while 65% (n=26) said it 
could be prevented by abstaining. 57.5% (n=23) of the respondents indicated that it can 
be prevented by avoiding infections and contaminated needles with 42.5% (n=17) saying 
this could be achieved by remaining faithful to one uninfected partner. Currently HIV/AIDS 
has no cure, which means that the world community has to look for possible prevention 
methods to mitigate its negative impact. Therefore the high level of knowledge exhibited 
by the participants on correct interventions of HIV prevention is a good beginning, as it is 
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often said that an individual knowledgeable about something is more likely to make 
informed choices and decisions than a person who has inadequate knowledge. 
 
Therefore it is inevitable to assume by extrapolating from these findings that the future 
ultimately is that we will have an informed society taking stringent precautions on issues of 
HIV/AIDS provided there is continued education and sensitization on HIV prevention. 
 
5.3   To determine knowledge and attitude of antiretroviral treatment. 
5.3.1 Knowledge on antiretroviral therapy 
Knowledge on antiretroviral therapy (ART) was assessed by asking the participants on 
what ARVs do. The study results showed that all except one had adequate knowledge 
with the majority (65%, n=26) of the respondents indicating that ART improves the 
function of the host’s protective immune system and prolongs life of people living with HIV 
and AIDS. A total of 60.0% (n=24) indicated that ART decrease the amount of virus in the 
body and reduce opportunistic infections. 
 
In Zambia like any other countries in the sub-Saharan African region, there are low literacy 
levels, however, given this comprehensive understanding of the pharmacological effects of 
ARVs shown by the respondents, one can postulate that the opposite can also be true. 
UNAIDS (2004) reported similar findings stating that antiretroviral therapy is lifesaving as 
they sited that approximately 5.5 million lives on ART were saved between 1996 and 2012 in 
low and middle income countries. One such study done by Cambiano et al (2011) on the 
effects of ARVs also reported similar findings. This study showed that ART given for the 
treatment of HIV increases immunity and thus in turn reducing the chances on one 
having opportunistic infections. 
 
5.3.2  Knowledge on guidelines regarding commencement of patients on ART 
When assessed on the commencement of ARVs, the majority of the respondents (76.9%, 
n=31) stated that ARVs should be started when CD4 count is ≤ 500 cells/mm3. These 
findings are in conformity with the eligibility criteria for HAART initiation in specific 
populations which state that; ART in all adult patients should be initiated when CD4 count 
falls less or equal to 500 cells per mm3. This includes symptomatic patients who are at 
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WHO clinical stage 3 and 4 of the disease. Those patients who have a CD4 count of less 
or equal to 350 cells/mm3 should be treated as top priority (WHO, 2013). 
 
5.3.3  Attitude of the patients towards antiretroviral treatment 
Results showed that the majority of the respondents had a positive (good) attitude with 
90% (n=36), stating that sex with a person on ART can still result in transmission of the 
HIV virus, 88% (n=35) indicating that patients on ART need to use a condom and 85% 
(n=34) stated that a condom should be used even with uninfected partners. 
 
5.4 To determine whether embarking on antiretroviral therapy has contributed 
towards sexual risk behavior. 
To assess a hypothesis reviewed in this study that there is a significant association 
between the availability of antiretroviral therapy and an upsurge in the occurrence of risky 
sexual behavior and unprotected sex, the period of time the participant had been on ART 
were cross tabulated with the number of sexual partners and condom usage. The study 
results revealed that the majority (82.5%, n=33) of respondents had sexual intercourse in 
the last 6 months. Only 17.5% (n=7) of the respondents did not have sexual intercourse. 
From the results, it could be assumed that the HIV seropositive status of the respondents 
did not translate into a decline in sexual relations. One possible reason for this trend could 
be attributed to the desire for people living with HIV and AIDS to have children. These 
findings are in agreement with what was reported by Makukula (2007) in Mansa Zambia 
as well as the University Teaching Hospital that patients on ART were more sexually 
active than those who were not on ART. Kennedy et al, (2007) also reported that, as a 
result of the improvement of the quality of life of people living with HIV and AIDS due to 
the availability of HAART there is a likelihood of them being encouraged to recommence 
normal aspects of life such as sexual activities. It is noteworthy that the more than half 
(78.8%, n=26) of the respondents who had sexual intercourse with partners in the last 6 
months adhered to secondary prevention by using a condom. When asked the reasons 
for using a condom, the majority (73.1%, n=19) stated that they wanted to avoid 
transmission of the HIV virus and other STIs. These responses were not in agreement 
with the findings of three concurrent studies Bouhnik et al, (2002); Stephenson et al, 
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(2003); and Stolte et al, (2006). Which reported that due to the availability of HAART, 
there is an upsurge in sexually transmitted infections and unprotected sex. 
 
This study has also revealed that there is no significant relationship between the period 
of time the participant had been on ART and having sexual intercourse, condom usage 
and the number of sexual partners. Similar findings were reported by a study conducted in 
Mombasa, Kenya by Sarna et al in 2005 that there is no evidence to conclude that the 
commencement of HAART leads to increase of risky sexual behavior. 
 
While it is accepted that the introduction of antiretroviral treatment has brought hope in 
prolonging the lives of those living with HIV and AIDS, careful thought must be taken 
before accepting the hypothesis that availability of antiretroviral drugs in some circles of 
society has brought about some negative thoughts in that some individuals have resorted to 
high risk behaviors. This is because sufficient evidence to confirm this notion is lacking. 
 
5.5 To provide guidelines on how to improve HIV prevention messages to support 
communities affected 
Finally, the respondents were asked to give suggestions on how to improve HIV 
prevention messages to support communities affected. In this study, most respondents 
(36%, n=11) commended that continued sensitization would improve HIV prevention 
messages to support communities affected. And further stating that the current efforts are 
satisfactory and that they should be continued. This implies that health promoters are 
providing good services. Few participants (29%, n=9) stated that: “promoting abstinence 
among the youths or use of a condom for those that are sexually active and intensifying 
VCT campaign would reduce HIV transmission”. 
 
It is noteworthy that 7% (n=2) of the respondents suggested that; “involving the families 
and communities affected, civic, religious, and traditional leaders to educate both the 
young and adult citizens in schools, colleges and churches to support and fight stigma 
and discrimination against people living with HIV would help.” An assumption is that this 
would translate to an increase in the number of counselors. A further 4% went on to state 
that available counselors should be motivated, another 4% stated there was need to 
increase VCT mobile sites and 2% stated that doctors, tutors and HIV patients should be 
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trained as counselors. HIV positive counselor would encourage utilization of VCT services 
as she/he may lead by example. 
 
Others stated that money that is utilized on HIV/AIDS seminars given, as allowances to 
workers should be directed to HIV/AIDS Patients who are the intended beneficiaries. 
These suggestions made by study Participants are some of the factors that influence the 
utilization of VCT services that need to be addressed in order to make HIV prevention in 
the community a reality. 
 
5.6 Limitations of the study 
5.6.1 Lack of scientific research findings on the relationship between sexual behavior 
and HAART made it difficult to have some of the findings supported. 
5.6.2 The sample comprised of HIV-positive participants on ART from Lusaka district 
only and hence this makes it difficult to generalise the findings to other settings and 
the entire country. 
5.6.3 The data collection tool used only targeted participants able to speak and write in 
English hence limiting those who could have given information in local language. 
 
5.7 Conclusions and recommendations 
5.6.1 Conclusions according to stated research objectives 
The study was carried out to investigate a relationship between sexual behavior and 
HAART. The study revealed that there is no significant relationship between the 
availability of HAART and risky sexual behavior amongst the study population. The 
subjective interpretations of an upsurge in the occurrence of risky sexual behavior and 
unprotected sex following successful ART though maybe consistent, there is need for 
more evidence to confirm this hypothesis. There was adequate knowledge on HIV and 
AIDS, its prevention and ART. It was also revealed that People living with HIV and AIDS 
have a good attitude towards antiretroviral treatment in this study. 
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5.6.2 Recommendations 
 The health sector in collaboration with other stakeholders such as the Ministry of 
Education, religious and traditional leaders to educate people in the communities on the 
consequences of HIV/AIDS so as to foster a reduction in high risky behavior practices. 
 
5.6.3 Recommendations for further research 
 There is need for the study to be duplicated in other geographical areas of the 
country to enable generalization of the results. 
 The study should also be conducted among participants using a data collection tool in 
local language. 
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Appendix 1; Tables 
APPENDICES 
 
Table1.participants who have been on ARVs for less than 60 months and whether had 
prote cted sex or not 
 whether had protected sex or 
not 
 
 
 
 
Total 
  
Yes 
 
No 
 
Participants who have been 
on ARVs for less than 60 
months 
 
20-39 months Count 
% within Participants who have been on 
ARVs for less than 60 months 
 
15 
 
4 19 
 
 
78.9% 
 
 
21.1% 
 
 
100.0% 
 
40-59 months Count 
 
% within Participants who have been on 
ARVs for 
less than 60 months 
 
5 
 
3 
 
8 
 
 
62.5% 
 
 
37.5% 
 
 
100.0% 
 
Total Count 
 
% within Participants who have been on ARVs for 
less than 60 months 
 
20 
 
7 
 
27 
 
 
74.1% 
 
 
25.9% 
 
 
100.0% 
 
 
Chi-Square Tests 
 
  
 
Value 
 
 
df 
 
 
Asymp. Sig. (2-sided) 
Exact Sig. (2- sided) Exact Sig. (1- sided) 
 
Pearson Chi-Square 
 
.793a 
 
1 
 
.373 
  
 
Continuity Correctionb 
 
.168 
 
1 
 
.682 
  
 
Likelihood Ratio 
 
.761 
 
1 
 
.383 
  
 
Fisher's Exact Test 
   
 
.633 
 
.332 
 
Linear-by-Linear Association 
 
.764 
 
1 
 
.382 
  
 
N of Valid Casesb 
 
27 
    
 
a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is 2.07. 
 
b. Computed only for a 2x2 table 
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Table 2: Participants who have been on ARVs for 60 months or longer * whether had 
protected sexual intercourse 
 
Crosstab 
 
 whether had protected sex or not  
 
 
 
Total 
  
Yes 
 
No 
 
Participants who have been on 
ARVs for 60 months or longer 
 
60-79 months Count 
 
% within Participants who have been on ARVs 
for 
60 months or longer 
 
4 
 
0 4 
 
 
100.0% 
 
 
.0% 
 
 
100.0% 
 
100-119 months Count 
% within Participants who have been on ARVs 
for 60 months or longer 
 
1 
 
0 
 
1 
 
 
100.0% 
 
 
.0% 
 
 
100.0% 
 
120-139 months Count 
 
% within Participants who have been on ARVs 
for 
60 months or longer 
 
5 
 
2 
 
7 
 
 
71.4% 
 
 
28.6% 
 
 
100.0% 
 
140-159 months Count 
 
% within Participants who have been on ARVs 
for 
60 months or longer 
 
1 
 
0 
 
1 
 
 
100.0% 
 
 
.0% 
 
 
100.0% 
 
180-200 Count 
% within Participants who have been on ARVs 
for 60 months or longer 
 
1 
 
1 
 
2 
 
 
50.0% 
 
 
50.0% 
 
 
100.0% 
 
Total Count 
% within Participants who have been on ARVs for 60 months or longer 
 
12 
 
3 
 
15 
 
 
80.0% 
 
 
20.0% 
 
 
100.0% 
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Chi-Square Tests 
 
 
 
Value 
 
df 
 
Asymp. Sig. (2-sided) 
 
Pearson Chi-Square 
 
2.946a 
 
4 
 
.567 
 
Likelihood Ratio 
 
3.864 
 
4 
 
.425 
 
Linear-by-Linear Association 
 
1.920 
 
1 
 
.166 
 
N of Valid Cases 
 
15 
  
 
a. 9 cells (90.0%) have expected count less than 5. The minimum expected count is .20. 
 
 
Table 3. Less than 60 months on ARV drugs and how many sexual partners 
 
Cross tabulation 
 
 How many partners have you 
had sex with in the last 6 months 
 
 
 
 
Total 
  
1 
 
2 
 
Participants who have been 
on ARVs for less than 60 
months 
 
20-39 months Count 
 
% within Participants who have 
been on ARVs for less than 60 
months 
 
17 
 
2 19 
 
 
 
 
 
89.5% 
 
 
 
 
 
10.5% 
 
 
 
 
 
100.0% 
 
40-59 months Count 
 
% within Participants who have 
been on ARVs for less than 60 
months 
 
8 
 
0 
 
8 
 
 
 
 
 
100.0% 
 
 
 
 
 
.0% 
 
 
 
 
 
100.0% 
 
Total Count 
 
% within Participants who have been on ARVs for less than 60 
months 
 
25 
 
2 
 
27 
 
 
 
 
 
92.6% 
 
 
 
 
 
7.4% 
 
 
 
 
 
100.0% 
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Chi-Square Tests 
 
  
 
Value 
 
 
df 
Asymp. Sig. (2- sided) Exact Sig. (2- sided) Exact Sig. (1- sided) 
 
Pearson Chi-Square 
 
.909a 
 
1 
 
.340 
  
 
Continuity Correctionb 
 
.022 
 
1 
 
.882 
  
 
Likelihood Ratio 
 
1.472 
 
1 
 
.225 
  
 
Fisher's Exact Test 
   
 
1.000 
 
.487 
 
Linear-by-Linear Association 
 
.876 
 
1 
 
.349 
  
 
N of Valid Casesb 
 
27 
    
 
a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is .59. 
 
b. Computed only for a 2x2 table 
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Table 4: 60 Months or longer on ARVs drugs and number of sexual partners 
 
Crosstab 
 
 How many partners have you 
had sex with in the last 6 months 
 
 
 
 
Total 
  
1 
 
2 
 
Participants who have been on 
ARVs for 60 months or longer 
 
60-79 months Count 
 
% within Participants who have been on 
ARVs for 60 months 
or longer 
 
3 
 
1 4 
 
 
 
75.0% 
 
 
 
25.0% 
 
 
 
100.0% 
 
100-119 months Count 
 
% within Participants who have been on 
ARVs for 60 months 
or longer 
 
1 
 
0 
 
1 
 
 
 
100.0% 
 
 
 
.0% 
 
 
 
100.0% 
 
120-139 months Count 
 
% within Participants who have been on 
ARVs for 60 months 
or longer 
 
7 
 
0 
 
7 
 
 
 
100.0% 
 
 
 
.0% 
 
 
 
100.0% 
 
140-159 months Count 
 
% within Participants who have been on 
ARVs for 60 months 
or longer 
 
1 
 
0 
 
1 
 
 
 
100.0% 
 
 
 
.0% 
 
 
 
100.0% 
 
180-200 
 
2 
 
0 
 
2 
 
100.0% 
 
.0% 
 
100.0% 
 
Total 
 
14 
 
1 
 
15 
 
93.3% 
 
6.7% 
 
100.0% 
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Chi-Square Tests 
 
 
 
Value 
 
df 
 
Asymp. Sig. (2-sided) 
 
Pearson Chi-Square 
 
2.946a 
 
4 
 
.567 
 
Likelihood Ratio 
 
2.849 
 
4 
 
.583 
 
Linear-by-Linear Association 
 
1.892 
 
1 
 
.169 
 
N of Valid Cases 
 
15 
  
 
a. 9 cells (90.0%) have expected count less than 5. The minimum expected count is .07. 
 
 
Table.5. Less than 60 Months on ARV drugs and whether had sexual intercourse in the 
last six months 
Crosstab 
 
 
 
Have you ever had sexual 
intercourse in the last 6 
months 
 
 
 
 
 
 
Total 
  
Yes 
 
No 
 
Participants who have been 
on ARVs for less than 60 
months 
 
20-39 months Count 
 
% within Participants who have been on 
ARVs for less than 60 
months 
 
19 
 
4 
 
23 
 
 
 
82.6% 
 
 
 
17.4% 
 
 
 
100.0% 
 
40-59 months Count 
 
% within Participants who have been on 
ARVs for less than 60 
months 
 
8 
 
2 
 
10 
 
 
 
80.0% 
 
 
 
20.0% 
 
 
 
100.0% 
 
Total Count 
 
% within Participants who have been on ARVs for less than 60 
months 
 
27 
 
6 
 
33 
 
 
 
81.8% 
 
 
 
18.2% 
 
 
 
100.0% 
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Chi-Square Tests 
 
  
 
Value 
 
 
df 
Asymp. Sig. (2- sided) Exact Sig. (2- sided) Exact Sig. (1- sided) 
 
Pearson Chi-Square 
 
.032a 
 
1 
 
.858 
  
 
Continuity Correctionb 
 
.000 
 
1 
 
1.000 
  
 
Likelihood Ratio 
 
.031 
 
1 
 
.859 
  
 
Fisher's Exact Test 
   
 
1.000 
 
.605 
 
Linear-by-Linear Association 
 
.031 
 
1 
 
.860 
  
 
N of Valid Casesb 
 
33 
    
 
a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is 1.82. 
 
b. Computed only for a 2x2 table 
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Table 6: 60 Months or longer on ARV drugs and whether had sexual intercourse in the last 
six months 
 
Crosstab 
 
 Have you ever had sexual 
intercourse in the last 6 months 
 
 
 
 
Total 
  
Yes 
 
No 
 
Participants who have been on 
ARVs for 60 months or longer 
 
60-79 months Count 
 
% within Participants who have 
been on ARVs for 60 months or 
longer 
 
4 
 
0 4 
 
 
 
 
 
100.0% 
 
 
 
 
 
.0% 
 
 
 
 
 
100.0% 
 
100-119 months Count 
 
% within Participants who have 
been on ARVs for 60 months or 
longer 
 
1 
 
1 
 
2 
 
 
 
 
 
50.0% 
 
 
 
 
 
50.0% 
 
 
 
 
 
100.0% 
 
120-139 months 
 
7 
 
1 
 
8 
 
87.5% 
 
12.5% 
 
100.0% 
 
140-159 months 
 
1 
 
1 
 
2 
 
50.0% 
 
50.0% 
 
100.0% 
 
180-200 
 
2 
 
1 
 
3 
 
66.7% 
 
33.3% 
 
100.0% 
 
Total 
 
15 
 
4 
 
19 
 
78.9% 
 
21.1% 
 
100.0% 
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Chi-Square Tests 
 
 
 
Value 
 
df 
 
Asymp. Sig. (2-sided) 
 
Pearson Chi-Square 
 
3.708a 
 
4 
 
.447 
 
Likelihood Ratio 
 
4.164 
 
4 
 
.384 
 
Linear-by-Linear Association 
 
1.130 
 
1 
 
.288 
 
N of Valid Cases 
 
19 
  
 
a. 9 cells (90.0%) have expected count less than 5. The minimum expected count is .42. 
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Appendix 2: Study Permission Letter 
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APPENDIX 3: RESPONDENTS QUESTIONNAIRE 
 
 
 
Ethics reference # SU-HSD-000293 
 
 
Questionnaire code #  
 
 
 
 
Self-completion Questionnaire 
 
 
The Impact of Antiretroviral Therapy on Risky Sexual Behaviour in People Living with 
HIV and AIDS (PLWHA) in Lusaka District of Zambia 
 
 
 
INSTRUCTIONS 
 
 
Thank you for participating in this study. The questionnaire is divided into section A, B, C and  
D. Please follow the instructions clearly and complete the questionnaire in privacy. Please 
answer the questions honestly and to the best of your personal knowledge and opinion. The 
information you provide will be anonymous and confidential. 
 
SECTION A: Social demographic Characteristics 
(Please tick√) 
1. Age group (years) 
18-29 
30-39 
 
40-49 
 
50-49  
 
50+  
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2. Sex  
Female  
Male 
 
 
3. Marital status  
Single 
Married  
Divorced Widowed 
 
 
4. Education 
Primary 
Secondary 
Tertiary None 
 
 
5. Occupation 
Employed 
Unemployed 
 
 
Access to Antiretroviral Therapy (ART) 
 
6. Are you on ART? YES                   NO 
  
7. How many months have you been on ART? 
 
 
 
 
SECTION B: Knowledge about HIV prevention 
measures 
 
 
8. HIV transmission can be prevented by? (please tick√ multiple responses allowed) 
 
i) Abstaining 
 
ii) Using a condom correctly and consistently 
iii) Every time you have sex 
 
iv) Remaining faithfully to one uninfected partner 
 
v) Avoiding infections and contaminated needles 
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vi) Don’t know 
 
vii) Other (specify) …………………………………………………………… 
 
 
SECTION C: Knowledge and attitude towards 
ART Knowledge about Antiretroviral 
(therapy ART) 
9. What do ARVs do? (please tick, multiple responses allowed) 
 
i) Cure HIV/AIDS 
 
ii) Increase sickness 
 
iii) Slow the progression of AIDS 
 
iv) Decrease the amount of virus in the body 
 
v) Improve immune system 
 
vi) Reduce opportunistic infections 
 
vii) Increase the CD 4 count 
 
viii) Prolongs life of people lining with HIV and AIDS 
 
ix) Kill people 
 
x) Don’t know 
 
xi) Other (specify) …………………………………………………………. 
 
 
 
10. When should a person with HIV and AIDS start taking ARVs? 
 
i) When they fall physically ill 
 
ii) When CD4 count is 500 and below 
 
iii) When they are unable to continue their daily activities due to illness 
 
iv) Not all positive people need to commence on ARVs 
 
v) Don’t know 
 
vi) Other (specify)……………………………………………………………. 
 
 
Attitude about ART and Sexual behavior (please tick √ single response) 
 
 
11. People who are on ART are less likely to transmit the HIV virus 
i) Strongly disagree 
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ii) Disagree 
 
iii) Agree 
 
iv) Strongly agree 
 
v) I don’t know 
 
 
 
12. Now that I am on ART I see no need of using condoms 
 
i) Strongly disagree 
 
ii) Disagree 
 
iii) Agree 
 
iv) Strongly agree 
 
v) I don’t know 
 
 
 
13. A person on ART cannot transmit HIV 
 
i) Strongly disagree 
 
ii) Disagree 
 
iii) Agree 
 
iv) Strongly agree 
 
v) I don’t know 
 
 
 
14. I see no need of using condoms with my sexual partners 
 
i) Strongly disagree 
 
ii) Disagree 
 
iii) Agree 
 
iv) I strongly agree 
 
v) I don’t know 
 
 
 
15. If you have sex with someone who is on ART you cannot contract HIV 
 
i) Strongly disagree 
 
ii) Disagree 
 
iii) Agree 
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iv) Strongly agree 
 
v) I don’t know 
 
 
Risky Sexual Behaviour Outcomes (please tick √) 
 
 
16. Have you ever had sexual intercourse in the last 6 months YES NO 
 
17. If YES to Q16 how many partners have you had in the last 6 months? 
 
18. Of these partner you have had how many are your 
 
i) Spouse 
 
ii) Girl/boy friend 
 
iii) Casual partner 
 
iv) Sex worker 
 
19. Which of you said partners did you last have sex with? 
 
i) Spouse 
 
ii) Girl/boy friend 
 
iii) Casual partner 
 
iv) Sex worker 
 
20. Did you use a condom when having sexual intercourse with your partner(s) 
YES NO 
 
 
21. If YES to Q20 what was the reason(s) for using a condom? 
 
i) Avoid transmission & HIV and other STIs 
 
ii) Avoid pregnancy 
 
iii) Pressured by partner 
 
iv) Others (specify)……………………………………………………………. 
 
22. If no to Q20 what was the reason (s) for not using a condom? 
 
i) Trusted partner 
 
ii) Increased pleasure 
 
iii) Pressured by partners 
 
iv) Other (specify)……………………………………………………………… 
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SECTION D 
 
23. Suggest ways on how to improve HIV prevention messages to support 
communities affected. 
……………………………………………………………………………………………… 
 
……………………………………………………………………………………………… 
 
……………………………………………………………………………………………… 
 
……………………………………………………………………………………………… 
 
……………………………………………………………………………………………… 
 
 
 
 
 
 
 
 
 
---------Thank you very much for participating in the study ----------- 
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APPENDIX 4: INDIVIDUAL CONSENT FORM 
 
 
 
STELLENBOSCH UNIVERSITY CONSENT TO PARTICIPATE IN RESEARCH 
 
THE IMPACT OF ANTIRETROVIRAL THERAPY ON RISKY SEXUAL BEHAVIOUR IN PEOPLE 
LIVING WITH HIV AND AIDS (PLWHA) IN LUSAKA DISTRICT OF ZAMBIA 
 
You are asked to take part in a research study conducted by Patrick Mukuka Chilufya a Master of Philosophy in 
HIV/AIDS Management student, from the Africa Centre for HIV/AIDS Management at Stellenbosch 
University. The results will be added to a long essay involving personal research by the mentioned student. 
You were selected as a possible contributor in this study because you meet the standards which include 
being HIV positive and on antiretroviral therapy for a minimum of one year. 
 
1. PURPOSE OF THE STUDY 
The reason for the study is to find out to what level the ease of use of antiretroviral treatment has had an 
effect on sexual risk behaviour practices in people living with HIV and AIDS (PLWHA) in order to provide 
ideas to improve HIV prevention messages. 
 
2. PROCEDURES 
If you volunteer to take part in this study, we would ask you to do the following things: 
i. You will be required to fill in a question paper about issues related to HIV treatment and your sexual 
experiences. 
ii. The distribution and filling in of the question sheet will be conducted within Network of Zambian People 
Living with HIV and AIDS approved premises. 
iii. The length of taking part in the study is 2 months. 
iv. It will take about 45 minutes to complete the question paper. 
 
3. POSSIBLE RISKS AND WORRIES 
i. One worry might be that of confidentiality of information collected. This will be dealt with by letting you know 
that the study is nameless and your identity will not be made public. Research records will be stored away 
in a safe place which will not be accessed by other people other than the person conducting the 
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research. 
ii. Some level of worry and feeling of shame may arise as a result of questions asked about sexual 
behaviour. This issue will be dealt with by giving special importance on confidentiality and secrecy of the 
study. The question paper will also be answered by yourself and will not involve you responding face-
to-face to the researcher. This will also reduce on the possibility of worry and embarrassment and the 
feeling of shame. 
iii. The research might lead to openings of a mark of shame, unfair treatment and punishment. This will be 
dealt with by the use of language that does not lead to shame and worry. There will be respect and 
protection for the freedom, rights and self-respect of you the participant. The participation in this study 
must be out of your own free will and based on your permission to carry out the study. 
iv. With information shared by the participant will there be any help that may be given on any issues relating to 
HIV and AIDS as well as others if there is need. There is need to refer or link the participants to support 
services available in the community under study. The Network of Zambian People living with HIV and AIDS 
conducts support and referral to a number of individuals and organisations that provide various services to 
its members ranging from psychosocial counselling, health services as well as other individual needs. The 
researcher will use the referral system that 
the organisation is currently using. The organisation will also refer to a named clinic if there is need. Clinics 
have Network of Zambian People Living with HIV and AIDS members present who can assist with any help 
needed. If there is referral need outside the clinic set up the District coordinator will facilitate the process. For 
Lusaka District the Coordinator is Mr. Eddie Fundanga; Cel: 0955/0965 648657; 
Email:eddiefundanga@gmail.com 
 
4. POTENTIAL BENEFITS TO SUBJECTS AND/OR TO SOCIETY 
You will be able to benefit from the research in that with the information provided will help in mitigating the 
spread of the HI virus at a personal level. The findings of the study will be made available to all 
participants’ part of the network by means of a report or brochure whose identifying particulars have been 
removed. 
 
Others who will benefit from this study will be those who will implement HIV and AIDS programs, NGOs 
and National AIDS council. Up-to-date information will be obtained and this will be combined with their 
work to improve HIV and AIDS programs. 
Those who implement HIV and AIDS programs will be able to compare their work against the study and 
therefor make improvements. The study will also help the Health Ministry in planning programs in the area of 
HIV and AIDS in Zambia. 
 
5. PAYMENT FOR PARTICIPATION 
You will not receive any payment for taking part in the study as its main purpose is for educational 
achievement. 
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6. CONFIDENTIALITY 
Any information that is obtained in connection with this study and that can be identified with you will remain 
confidential and will be made known only with your permission or as required by law. Confidentiality will be 
kept by means of: 
i. Storing research records in a secure place which include secure secret code on the computer and locked 
filing cabinet. 
ii. Controlled right to use the information which is gathered. 
iii. Proper throwing away of records used such as question forms. 
iv. Having a system of signals used to represent letters or numbers and making information secret collected 
so that research participants are not known. 
 
If any information will be released it will have to be the research supervisor who is providing guidance to the 
investigator to complete the study. The type of the information shared will not contain the personal details 
of the participant. 
The researcher will print out results of study in form of a long essay presentation. Confidentiality will be 
kept by not publishing personal details of the research participant(s) 
 
7. PARTICIPATION AND WITHDRAWAL 
You can choose whether to be in this study or not. If you volunteer to be in this study, you may pull out at 
any time without punishments of any kind. You may also refuse to answer any questions you don’t want to 
answer and still remain in the study. The investigator may withdraw you from this research if circumstances 
arise which warrant doing so. Conditions under which the subject's participation may be ended by the 
investigator without considering the subject's consent may include not being in the right frame of mind to 
answer the questions. This might also include bodily illness. 
The investigator may also withdraw participation if the participant does not abide to the set rules and 
guidelines of the study. 
 
8. IDENTIFICATION OF INVESTIGATORS 
If you have any questions or concerns about the research, please feel free to contact Principal Investigator: 
Patrick Chilufya Cell# 0967 746022 or 0977 746022; 
Supervisor: Dr. Greg Munro, Stellenbosch University, Tel: +27 21 808 3006 | Fax: +27 21 808 3015; Email: 
gmunro@aidsalliance.org 
 
9. RIGHTS OF RESEARCH SUBJECTS 
You may withdraw your agreement at any time and stop taking part without punishment given. You are not 
giving up any legal entitlements, rights or remedies because of your participation in this research study. If you 
Stellenbosch University  https://scholar.sun.ac.za
58  
have questions regarding your rights as a research subject, contact Ms Maléne Fouché 
[mfouche@sun.ac.za; 021 808 4622] at the Division for Research Development. 
 
 
SIGNATURE OF RESEARCH SUBJECT OR LEGAL REPRESENTATIVE 
 
The information above was described to me by Mr. Patrick Chilufya in English and I am in understanding of 
this language or it was reasonably translated to me. I was given the opportunity to ask questions and these 
questions were answered to my satisfaction. 
 
I hereby consent voluntarily to participate in this study. I have been given a copy of this form. 
 
 
 Name of Subject/Participant 
 
 
Name of Legal Representative (if applicable) 
 
 
 Signature of Subject/Participant or Legal Representative Date 
 
 
SIGNATURE OF INVESTIGATOR 
 
I declare that I explained the information given in this document to  [name of the 
subject/participant] and/or [his/her] representative [name of the representative]. 
[He/she] was encouraged and given ample time to ask me any questions. This conversation was conducted in  
English/Bemba/Nyanja  and  [no  translator  was  used/this  conversation  was  translated  into    
by ]. 
 
 
 Signature of Investigator Date 
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APPENDIX 5: RESEARCH ETHICS COMMITTEE APPROVAL LETTER 
 
Approval Notice 
 
Response to Modifications‐ (New Application) 
 
22‐Jun‐2015 Chilufya, Patrick PM Proposal #: SU‐HSD‐000293 Title: 
THE IMPACT OF ANTIRETROVIRAL THERAPY ON RISKY SEXUAL BEHAVIOUR IN PEOPLE LIVING 
WITH HIV AND AIDS (PLWHA) IN LUSAKA DISTRICT OF ZAMBIA 
 
Dear Mr Patrick Chilufya, 
 
Your Response to Modifications ‐ (New Application) received on 17‐Apr‐2015, was reviewed by members of 
the Research Ethics Committee: Human Research (Humanities) via Expedited review procedures on 15‐Jun‐
2015 and was approved. Please note the following information about your approved research proposal: 
 
Proposal Approval Period: 15‐Jun‐2015 ‐14‐Jun‐2016 
 
Please take note of the general Investigator Responsibilities attached to this letter. You may commence with 
your research after complying fully with these guidelines. 
 
Please remember to use your proposal number (SU‐HSD‐000293) on any documents or correspondence 
with the REC concerning your research proposal. 
 
Please note that the REC has the prerogative and authority to ask further questions, seek additional 
information, require further modifications, or monitor the conduct of your research and the consent process. 
 
Also note that a progress report should be submitted to the Committee before the approval period has 
expired if a continuation is required. The Committee will then consider the continuation of the project for a 
further year (if necessary). 
 
This committee abides by the ethical norms and principles for research, established by the Declaration of 
Helsinki and the Guidelines for Ethical 
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Research: Principles Structures and Processes 2004 (Department of Health). Annually a number of projects 
may be selected randomly for an external audit. 
 
National Health Research Ethics Committee (NHREC) registration number REC‐050411‐032. 
 
We wish you the best as you conduct your research. 
 
If you have any questions or need further help, please contact the REC office at 218089183. 
 
Included Documents: 
 
DESC Report ‐ Davis, Herbert 
 
REC: Humanities New Application Sincerely, 
Clarissa Graham REC Coordinator Research Ethics Committee: Human Research (Humanities) 
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